
Latin America Pet Therapeutic Diet Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The Latin America pet therapeutic diet market size was estimated at USD 337.8 million in 2024. The market is expected to grow from USD 358.8 million in 2025 to USD 714.9 million in 2034, at a CAGR of 8%, according to the latest report published by Global Market Insights Inc.

One of the major growth drivers for Latin America's pet therapeutic diet market is the robust increase in pet ownership and the pet humanization trend. For instance, as per Statista, in 2022, there were approximately 187 million pets in Latin America. This represents a growth of 17% in the pet population compared to the number in 2017, which stood at 160 million pets throughout the region. Pets are being increasingly treated as part of the family by individuals and families from all over the region, driving more expenditure on premium care, health, and wellness products.
Pet therapeutic diet, also known as prescription diet, is specialized pet food designed to be fed to pets with specific health conditions or diseases. They help to treat, prevent, or manage several health conditions such as kidney diseases, diabetes, gastrointestinal issues, skin conditions, and urinary tract issues, among others. They are distinct from regular pet food as they are specially formulated with targeted nutrient profiles and are typically prescribed or recommended by veterinarians to improve pets’ quality of life and aid in medical treatment.
Key players such as Purina PetCare (Nestle SA), Mars, Hill's Pet Nutrition (Colgate Palmolive), Farmina Pet Foods, and Virbac lead the market with their wide product portfolio and robust R&D. These players benefit from strong veterinarian recommendations, brand recognition, and extensive R&D capabilities to introduce science-backed therapeutic diets. Collectively, these players drive innovation, grow veterinary partnerships, and increase awareness, positioning therapeutic diets as a rapidly expanding category in the pet nutrition market.
The Latin America pet therapeutic diet market witnessed steady growth, growing from USD 267.1 million in 2021 to USD 319.3 million in 2023. Between 2021 and 2023, the market experienced a phase of robust growth as pet ownership surged, and health-focused nutrition became a greater concern for pet parents. In addition, the market witnessed growth owing to a surge in pet adoption during the COVID period, which translated directly into increasing demand for niche diets used to treat obesity, digestive diseases, kidney disorders, and allergies.
During the COVID-19 pandemic, pet ownership increased globally, especially in Latin America, according to the USDA FAS. In 2023, Latin America imported USD 259 million worth of dog and cat food, a 75% increase since 2020. This shift led to a surge in the overall pet care market as new pet parents began spending more on their pets' health and overall well-being.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2024 |
| Market Size in 2024 | USD 337.8 Million |
| Market Size in 2025 | USD 358.8 Million |
| Forecast Period 2025 - 2034 CAGR | 8% |
| Market Size in 2034 | USD 714.9 Million |
| Key Market Trends | |
| Drivers | Impact |
| Rising pet population and growing trend of pet humanization | High adoption of pets for companionship has boosted the demand for various pet care products. Families in Latin America increasingly treat pets as members of the household, which encourages higher spending on specialized nutrition aimed at improving health and longevity. |
| Rise in chronic health issues among pets | Conditions such as obesity, digestive problems, and joint disorders are becoming more common, leading veterinarians to recommend therapeutic diets as part of treatment. |
| Improved access through diverse sales channels | The availability of specialized diets is expanding beyond veterinary clinics into e-commerce and modern retail, making these products more visible and easier to purchase. |
| Premiumization and innovation in formulations | Pet owners are increasingly willing to spend more on high-quality, natural, and tailored diets for pets. Manufacturers are responding with innovative formulations, such as grain-free, hypoallergenic, and breed- or age-specific diets, expanding consumer choice and supporting long-term market expansion. |
| Pitfalls & Challenges | Impact |
| High product cost relative to income levels | Therapeutic diets are priced at a premium, which makes them less affordable for a large section of pet owners in Latin America. |
| Uneven veterinary infrastructure and awareness | Limited access to veterinarians in rural or less-developed areas restricts both awareness and adoption of prescription-based pet diets. |
| Opportunities: | Impact |
| Launch of affordable, locally adapted product lines | Launching cost-effective formulations or smaller pack sizes tailored to regional needs can attract budget-conscious consumers without compromising nutritional value. |
| Growth of tele-veterinary and digital veterinary platforms | Leveraging digital platforms for veterinary consultations, combined with subscription or direct-to-consumer delivery models, can significantly widen market reach. |
| Market Leaders (2024) | |
| Market Leaders |
27.4% market share. |
| Top Players |
Collective Market Share 62.5% |
| Competitive Edge |
|
| Regional Insights | |
| Largest Market | Brazil |
| Fastest Growing Market | Mexico |
| Emerging Countries | Argentina, Colombia, Peru |
| Future outlook |
|

Based on the product type, the Latin America market is classified into dry food, wet/canned food, and other product types. The dry food segment dominated the market in 2024 and was valued at USD 198.3 million. On the other hand, the wet/canned food segment was valued at USD 96.9 million in 2024 and is poised to witness high growth over the coming years. Wet/canned therapeutic diets are favored for their high moisture content, palatability, and ease of consumption. Increasing knowledge of the health advantages linked with water-dense diets, coupled with increased availability through online stores and veterinary clinics, is leading to steady expansion in the wet food category throughout the region.

Based on the animal type, the Latin America pet therapeutic diet market is segmented into cats, dogs, and other animal types. In 2024, the dogs segment accounted for the largest share of 67.1% in the Latin America market.
Based on the health condition, the Latin America pet therapeutic diet market is categorized into renal health, gastrointestinal health, skin and coat health, cardiovascular health, weight management, joint care, and other health conditions. The weight management segment dominated the market in 2024 with a revenue of USD 82.6 million.
Based on the distribution channel, the Latin America pet therapeutic diet market is categorized into veterinary hospitals and clinics, e-commerce, retail pharmacies, and other distribution channels. The veterinary hospitals and clinics segment dominated the market in 2024 and was valued at USD 159.6 million.

The Brazil pet therapeutic diet market was valued at USD 107.6 million and USD 121.1 million in 2021 and 2022, respectively. The market size reached USD 137.8 million in 2024, growing from USD 129.7 million in 2023.
Mexico pet therapeutic diet market is anticipated to grow at a significant CAGR over the analysis period, driven by rising pet ownership, urbanization, and greater awareness of pet health.
Argentina's pet therapeutic diet market is expanding rapidly, supported by the country’s strong culture of pet ownership and rising emphasis on pet wellness.
The Latin America market is characterized by intense competition, with participation from multinational companies, specialized pet nutrition companies, and emerging niche brands. Top 5 players such as Purina PetCare (Nestle SA), Mars, Incorporated, Hill's Pet Nutrition (Colgate Palmolive), Farmina Pet Foods, and Virbac account for 62.5% of the market share. These players emphasize mergers and acquisitions, partnerships, and collaboration for expanding their business. They leverage a strong reputation, extensive R&D capabilities, and a significant distribution network to provide science-backed therapeutic diets addressing specific health conditions in pets.
Meanwhile, emerging and specialty brands such as Affinity Petcare, Animonda, Stella & Chewy’s, Champion Petfoods, and Diamond Pet Foods are differentiating through transparency in sourcing, customized nutrition plans, and sustainability-driven approaches. This dynamic competitive landscape is shaped by innovation, veterinary partnerships, and growing consumer preference for health-focused diets that enhance pet’s health.
Few of the prominent players operating in the Latin America pet therapeutic diet industry include:
Purina leads the Latin America market with a share of 27.4% in 2024, leveraging its strong R&D infrastructure, veterinary partnerships, and consumer trust to deliver diets that combine high therapeutic efficacy with optimal taste and digestibility. Its products are supported by extensive clinical testing, peer-reviewed studies, and continuous innovation in nutrient bioavailability and formulation precision.
Through its renowned brands, including Royal Canin, the company offers clinically formulated nutritional solutions designed to address a wide range of health conditions such as renal disorders, gastrointestinal sensitivities, dermatological issues, and weight management. Mars integrates cutting-edge R&D, veterinary science, and clinical trials via its Waltham Petcare Science Institute, ensuring evidence-based diet formulations that meet both therapeutic efficacy and palatability standards.
Hill’s works closely with veterinarians globally, integrating its solutions into professional practice. The company’s commitment to nutritional precision is supported by collaboration with academic research institutions and pet health networks, enabling the continuous refinement of therapeutic formulations.
Market, By Product Type
Market, By Animal Type
Market, By Health Condition
Market, By Distribution Channel
The above information is provided for the following countries:
The cat segment is expected to grow at a CAGR of 8.4% through 2034, driven by rising cat ownership and increasing awareness of feline-specific health nutrition.
Key players include Purina PetCare (Nestlé SA), Mars Incorporated, Hill’s Pet Nutrition (Colgate Palmolive), Farmina Pet Foods, and Virbac. Collectively, the top five players hold 62.5% market share.
Brazil led the region with USD 137.8 million in 2024, supported by high pet ownership and a well-established veterinary care infrastructure.
The wet/canned food segment was valued at USD 96.9 million in 2024, favored for its high moisture content and palatability.
The market size was USD 337.8 million in 2024, supported by rising pet ownership and growing awareness of health-focused pet nutrition.
The Latin America pet therapeutic diet market is expected to be valued at USD 358.8 million in 2025.
The dry food segment generated USD 198.3 million in 2024, dominating the market due to convenience, affordability, and longer shelf life.
The market is expected to reach USD 714.9 million by 2034, growing at a CAGR of 8% during 2025–2034.


